May 2024
We are very happy to announce a change in the inclusion criteria for the TUBA-WISP II study. From this point forward, also PALB2 PV carriers can be included. The other included pathogenic variants remain the same: BRCA1, BRCA2, RAD51C, RAD51D and BRIP1.
The lifetime risk for ovarian cancer with a PALB2 PV ranges from 3-5% and a risk-reducing surgery can be considered when the lifetime risk is >5%. Individual factors influence the personal risk assessment, and therefore we decided to also include the PALB2 PV carriers that are eligible for risk-reducing surgery. We recommend to consider for every individual patient whether or not the benefits of risk-reducing surgery outweigh the risks. An individual risk assessment tool could be used to quantify the ovarian cancer risk (like CanRisk).
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/palb2-engels-high.png?enable-io=true&enable=upscale&crop=1050%2C600%2Cx0%2Cy0%2Csafe&width=900&height=514)
March 2024
At the European Society for Gynaecological Oncology conference (ESGO) we held the TUBA-WISP II invesitgators meeting! We were very happy to welcome a lot of the participating centres and to discuss the study with everyone.
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/kxu9ok/picturetuba-wispiiinvestigatorsmetlogo.jpg?enable-io=true&enable=upscale&crop=1280%2C960%2Cx0%2Cy0%2Csafe&width=900&height=675)
March 2024
We are very happy to announce that we are halfway with our inclusions! We've currently reached 1500 out of the intended 3000 inclusions!
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/green-white-simple-thank-you-banner-landscape-high-g70wlh.png?enable-io=true&enable=upscale&crop=1920%2C960%2Cx0%2Cy0%2Csafe&width=900&height=450)
Newsletter March 2024
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/nieuwsbrief-maart-2024-1e-pagina-high.png?enable-io=true&enable=upscale&crop=599%2C848%2Cx0%2Cy0%2Csafe&width=438&height=620)
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/nieuwsbrief-maart-2024-2e-pagina-high.png?enable-io=true&enable=upscale&crop=616%2C872%2Cx0%2Cy0%2Csafe&width=438&height=620)
Newsletter December 2023
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/cpy6k1/dec2023pagina1.png?enable-io=true&enable=upscale&crop=793%2C1123%2Cx0%2Cy0%2Csafe&width=438&height=621)
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/hss0ox/dec2023pagina2.png?enable-io=true&enable=upscale&crop=792%2C1121%2Cx0%2Cy0%2Csafe&width=438&height=620)
Newsletter September 2023
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/0l4kn3/nieuwsbrief09-2023png-1.png?enable-io=true&enable=upscale&crop=974%2C785%2Cx0%2Cy0%2Csafe&width=900&height=725)
Newsletter November 2022
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/3nqazf/newsletternov2022png.png?enable-io=true&enable=upscale&crop=616%2C886%2Cx0%2Cy0%2Csafe&width=556&height=800)
Newsletter June 2022
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/uzqpkn/newsletterjune2022png.png?enable-io=true&enable=upscale&crop=620%2C890%2Cx0%2Cy0%2Csafe&width=557&height=800)
Newsletter March 2022
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/a0fu53/newslettermarch2022png.png?enable-io=true&enable=upscale&crop=616%2C871%2Cx0%2Cy0%2Csafe&width=565&height=799)
Newsletter December 2021
Newsletter September 2021
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/14xchr/newslettersept2021png.png?enable-io=true&enable=upscale&crop=603%2C865%2Cx0%2Cy0%2Csafe&width=557&height=799)
Newsletter June 2021
![](https://primary.jwwb.nl/public/g/a/l/temp-rvqgpqwllbcmtjkyhsmx/83k57d/newsletterjune2021png.png?enable-io=true&enable=upscale&crop=611%2C874%2Cx0%2Cy0%2Csafe&width=559&height=800)